Explore a vendor showcase presentation from the 2022 Cancer Genomics Consortium Annual Meeting that delves into internalizing a comprehensive genomic profiling solution with a path to reimbursement. Learn about the challenges faced in cancer genomics, including peer pressure and patient burden, and discover why PGDX was chosen as a solution. Gain insights into the approval process, workflow implementation, and reimbursement strategies. Examine a lab snapshot and summary of the presented information, providing valuable knowledge for professionals in the field of clinical cancer genomics.